Bulletproof Market

It is Friday. Big week. Third big week.

Where the heck are the profit-takers?

I have to believe they would be willing to overwhelm the markup folks, especially this close to the end of the quarter when the once-nonexistent regulators might enforce laws again.

Look at the stocks that are back on the case: Abbott Laboratories (ABT - commentary - Cramer's Take), Procter & Gamble (PG - commentary - Cramer's Take) and General Mills (GIS - commentary - Cramer's Take). Can you imagine if they ignite Pepsico (PEP - commentary - Cramer's Take) and Coca-Cola (KO - commentary - Cramer's Take)? Can you imagine if McDonald's (MCD - commentary - Cramer's Take) catches a big gain?

The Genentech (DNA - commentary - Cramer's Take) money is flowing to Amgen (AMGN - commentary - Cramer's Take) and Gilead (GILD - commentary - Cramer's Take). Soon to be in Cephalon (CEPH - commentary - Cramer's Take)? More of a move in Genzyme (GENZ - commentary - Cramer's Take)? A turn in Celgene (CELG - commentary - Cramer's Take)?

Housing's helping -- that great KB Homes (KBH - commentary - Cramer's Take) quarter shows a bottom, but it's more than that. It's a feeling that in the absence of industrial buying, we will pile into St. Jude Medical (STJ - commentary - Cramer's Take); Becton, Dickinson and Company (BDX - commentary - Cramer's Take); and Zimmer (ZMH - commentary - Cramer's Take).

In the meantime, I believe oil will not go down a lot despite the amazing contraction in natural gas. Chevron (CVX - commentary - Cramer's Take) and BP (BP - commentary - Cramer's Take) just will not be able to stay down.

How can the Nasdaq not be down big? Apple (AAPL - commentary - Cramer's Take) is barely touched. Google (GOOG - commentary - Cramer's Take) only down 2? The moment is positive.

We just can't crush it!

ALL JIM CRAMER BLOG ENTRIES | POST A COMMENT | READ COMMENTS  

---

At the time of publication, Cramer was long Gilead, Celgene, Chevron, BP, General Mills and Abbott Laboratories. Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here.

TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com.